WALTHAM, Mass.--(BUSINESS WIRE)--Jul. 28, 2016--
OvaScienceSM (NASDAQ: OVAS), a global fertility company
focused on the discovery, development and commercialization of new
treatment options, announced today that it will host a conference call
at 4:30 p.m. EDT on Thursday, August 4, 2016 to discuss second quarter
2016 financial results and provide a general corporate update.
The live call can be accessed by dialing +1-888-424-8151 for U.S.
callers and +1-847-585-4422 for international callers five minutes prior
to the start of the call and by providing the passcode 9515417. A live
webcast of the conference call will be available online from the
Investors section of the Company’s website at www.ovascience.com.
A replay of the conference call will be available from 7:00 p.m. EDT on
Thursday, August 4, 2016 through 11:59 p.m. EDT on Thursday, August 11,
2016, and may be accessed by visiting OvaScience’s website or by dialing
+1-888-843-7419 for U.S. callers and +1-630-652-3042 for international
callers. The replay access code is 9515417.
OvaScienceSM (NASDAQ: OVAS) is a global fertility company
dedicated to improving treatment options for women around the world.
OvaScience is discovering, developing and commercializing new fertility
treatments because we believe women deserve more options. Each
OvaScience treatment is based on the Company’s proprietary technology
platform that leverages the breakthrough discovery of egg precursor
(EggPCSM) cells – immature egg cells found inside the
protective ovarian lining. The AUGMENTSM treatment, a
fertility option specifically designed to improve egg health, is
available in certain IVF clinics in select international regions.
OvaScience has commenced a non-commercial preceptorship training program
with the OvaPrimeSM treatment, which could increase a woman’s
egg reserve, and is developing the OvaTureSM treatment, a
potential next-generation IVF treatment that could help a woman produce
healthy, young, fertilizable eggs without hormone injections. OvaScience
treatments are not available in the U.S. For more information, please
and connect with us on Twitter
View source version on businesswire.com: http://www.businesswire.com/news/home/20160728006406/en/
Media and Investor Contact:
Viera, + 1 617-420-8748